Department of Reconstructive Sciences, UConn Health, Farmington, Connecticut, USA.
Department of Medicine, Tufts University School of Medicine, Maine Medical Center Research Institute, Scarborough, Maine, USA.
Stem Cells. 2020 Jun;38(6):769-781. doi: 10.1002/stem.3159. Epub 2020 Feb 21.
Bone remodeling and regeneration are dependent on resident stem/progenitor cells with the ability to replenish mature osteoblasts and repair the skeleton. Using lineage tracing approaches, we identified a population of Dmp1+ cells that reside within cortical bone and are distinct from osteocytes. Our aims were to characterize this stromal population of transcortical perivascular cells (TPCs) in their resident niche and evaluate their osteogenic potential. To distinguish this population from osteoblasts/osteocytes, we crossed mice containing inducible DMP1CreERT2/Ai9 Tomato reporter (iDMP/T) with Col2.3GFP reporter (ColGFP), a marker of osteoblasts and osteocytes. We observed iDMP/T+;ColGFP- TPCs within cortical bone following tamoxifen injection. These cells were perivascular and located within transcortical channels. Ex vivo bone outgrowth cultures showed TPCs migrated out of the channels onto the plate and expressed stem cell markers such as Sca1, platelet derived growth factor receptor beta (PDGFRβ), and leptin receptor. In a cortical bone transplantation model, TPCs migrate from their vascular niche within cortical bone and contribute to new osteoblast formation and bone tube closure. Treatment with intermittent parathyroid hormone increased TPC number and differentiation. TPCs were unable to differentiate into adipocytes in the presence of rosiglitazone in vitro or in vivo. Altogether, we have identified and characterized a novel stromal lineage-restricted osteoprogenitor that is associated with transcortical vessels of long bones. Functionally, we have demonstrated that this population can migrate out of cortical bone channels, expand, and differentiate into osteoblasts, therefore serving as a source of progenitors contributing to new bone formation.
骨骼重塑和再生依赖于具有补充成熟成骨细胞和修复骨骼能力的驻留干细胞/祖细胞。通过谱系追踪方法,我们鉴定了一群位于皮质骨内且与骨细胞不同的 Dmp1+细胞。我们的目的是在其驻留龛位中对这种跨皮质血管周围细胞(TPC)基质群进行特征描述,并评估其成骨潜能。为了将该群体与成骨细胞/骨细胞区分开来,我们将含有诱导型 DMP1CreERT2/Ai9 Tomato 报告基因(iDMP/T)的小鼠与 Col2.3GFP 报告基因(ColGFP)(成骨细胞和骨细胞的标志物)杂交。我们在注射他莫昔芬后观察到 iDMP/T+;ColGFP- TPC 存在于皮质骨内。这些细胞是血管周围的,位于跨皮质通道内。离体骨外生培养显示 TPC 从通道迁移到平板上,并表达干细胞标志物,如 Sca1、血小板衍生生长因子受体β(PDGFRβ)和瘦素受体。在皮质骨移植模型中,TPC 从皮质骨内的血管龛位迁移并有助于新成骨细胞形成和骨管闭合。间歇性甲状旁腺激素治疗增加了 TPC 数量和分化。在体外或体内用罗格列酮处理时,TPC 不能分化为脂肪细胞。总之,我们已经鉴定和描述了一种新型的基质谱系受限的成骨前体细胞,它与长骨的跨皮质血管有关。功能上,我们已经证明该群体可以从皮质骨通道迁移出来、扩增并分化为成骨细胞,因此作为新骨形成的祖细胞来源。